Regioselective Late-Stage C-3 Functionalization of Pyrazolo[3,4-b]pyridines

Abstract

This contribution reports for the first time the late-stage C–H activation of pyrazolo[3,4-b]pyridine derivatives. A family of 16 molecules functionalized on the C-3 position by this methodology is demonstrated. After a careful optimization, a reliable procedure has been developed with Pd(phen)₂(PF₆)₂ catalyst (10 mol%), affording C-3 arylated pyrazolo[3,4-b]pyridines in yields ranging from 40 to 81%.

Key words

C–H activation - nitrogen heterocycles - palladium - pyrazolo-[3,4-b]pyridine

• References

• 1 Gaston MA. Dias LR. S. Freitas AC. C. Miranda AL. P. Barreiro EJ. Pharm. Acta Helv. 1996; 71: 213
• 2a Ochiai H. Ishida A. Ohtani T. Kusumi K. Kishikawa K. Yamamoto S. Takeda H. Obata T. Nakai H. Toda M. Bioorg. Med. Chem. 2004; 12: 4089
• 2b Allen D. Coe D. Cook C. Dowle M. Edlin C. Hamblin J. Johnson M. Jones P. Knowles R. Lindvall M. Mitchell C. Redgrave A. Trivedi N. Ward P. Patent WO2004/024728, 2004
• 2c Revesz L. Blum E. Di Padova FE. Buhl T. Feifel R. Gram H. Hiestand P. Manning U. Neumann U. Rucklin G. Bioorg. Med. Chem. Lett. 2006; 16: 262
• 2d Palle V. Balanchandran S. Gupta N. Khairnar V. Ramaiah R. Ray A. Dastidar S. Patent WO2007/031838, 2007
• 3 Straub A. Benet-Buckholz J. Fröde R. Kern A. Kohlsdorfer C. Schmitt P. Schwarz T. Siefert H.-M. Stasch J.-P. Bioorg. Med. Chem. 2002; 10: 1711
• 4 Höhn H. Polacek I. Schulze E. J. Med. Chem. 1973; 16: 1340
• 5 Huang S. Lin R. Yu Y. Lu Y. Connolly PJ. Chiu G. Li S. Emanuel SL. Middleton SA. Bioorg. Med. Chem. Lett. 2007; 17: 1243
• 6 Tucker TJ. Sisko JT. Tynebor RM. Williams TM. Felock PJ. Flynn JA. Lai M.-T. Liang Y. McGaughey G. Liu M. Miller M. Moyer G. Munshi V. Perlow-Poehnelt R. Prasad S. Reid JC. Sanchez R. Torrent M. Vacca JP. Wan B.-L. Yan Y. J. Med. Chem. 2008; 51: 6503
• 7a Patel JB. Malick JB. Salama AI. Goldberg ME. Pharmacol. Biochem. Behav. 1985; 23: 675
• 7b Bare TM. McLaren CD. Campbell JB. Firor JW. Resch JF. Walters CP. Salama AI. Meiners BA. Patel JB. J. Med. Chem. 1989; 32: 2561
• 8 Bandarage UK. Clark MP. Perola E. Gao H. Jacobs MD. Tsai A. Gillespie J. Kennedy JM. Maltais F. Ledeboer MW. Davies I. Gu W. Byrn RA. Nti Addae K. Bennett H. Leeman JR. Jones SM. O’Brien C. Memmott C. Bennani Y. Charifson PS. ACS Med. Chem. Lett. 2017; 8: 261
• 9 Anand D. Yadav PK. Patel OP. S. Parmar N. Maurya RK. Vishwakarma P. Raju KS. R. Taneja I. Wahajuddin M. Kar S. Yadav PP. J. Med. Chem. 2017; 60: 1041
• 10 Lavrard H. Popowycz F. Eur. J. Org. Chem. 2017; 600
• 11 Fuse S. Morita T. Johmoto K. Uekusa H. Tanaka H. Chem. Eur. J. 2015; 21: 14370
• 12 Iaroshenko VO. Gevorgyan A. Davydova O. Villinger A. Langer P. J. Org. Chem. 2014; 79: 2906
• 13 Goikhman R. Jacques TL. Sames D. J. Am. Chem. Soc. 2009; 131: 3042
• 14a Ben-Yahia A. Naas M. El Kazzouli S. Essassi EM. Guillaumet G. Eur. J. Org. Chem. 2012; 7075
• 14b Naas M. El Kazzouli S. Essassi EM. Bousmina M. Guillaumet G. J. Org. Chem. 2014; 79: 7286
• 14c El Kazzouli S. Guillaumet G. Tetrahedron 2016; 72: 6711
• 15 Hattori K. Yamaguchi K. Yamaguchi J. Itami K. Tetrahedron 2012; 68: 7605
• 16 Ye M. Edmunds AJ. F. Morris JA. Sale D. Zhang Y. Yu J.-Q. Chem. Sci. 2013; 4: 2374
• 17a Bontempi A. Alessio E. Chanos G. Mestroni G. J. Mol. Catal. 1987; 42: 67
• 17b Scarel A. Milani B. Zangrando E. Stener M. Furlan S. Fronzoni G. Mestroni G. Gladiali S. Carfagna C. Mosca L. Organometallics 2004; 23: 5593
• 18a Shibahara F. Yamaguchi E. Murai T. Chem. Commun. 2010; 46: 2471
• 18b Shibahara F. Yamaguchi E. Murai T. J. Org. Chem. 2011; 76: 2680
• 18c Yamaguchi E. Shibahara F. Murai T. Chem. Lett. 2011; 40: 939
• 18d Yamauchi T. Shibahara F. Murai T. Org. Lett. 2015; 17: 5392